• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza A induces the major secreted airway mucin MUC5AC in a protease-EGFR-ERK-Sp1 dependent pathway

tetano

Editor, Senior Moderator
Am J Respir Cell Mol Biol. 2012 Mar 1. [Epub ahead of print]
Influenza A induces the major secreted airway mucin MUC5AC in a protease-EGFR-ERK-Sp1 dependent pathway.
Barbier D, Garcia-Verdugo I, Pothlichet J, Khazen R, Descamps D, Rousseau K, Thornton D, Si-Tahar M, Touqui L, Chignard M, Sallenave JM.
Source

Unit? D?fense Inn?e et Inflammation, Institut Pasteur, Paris, France.
Abstract

Rationale : Mucins, the main glycoproteins present within mucus, modulate rheologic properties of airways and participate in lung defense. They are thought to be able to trap and eliminate micro-organisms from the lung. Among the mucins secreted in the lung, MUC5AC is the most prominent factor secreted by surface epithelial cells. Objectives : Although much is known about the signaling pathways involved in MUC5AC regulation by host factors such as cytokines or proteases, less is known about the pathways triggered by micro-organisms and specifically, by influenza A virus (IAV). We therefore set up to dissect the molecular mechanisms responsible for the potential modulation of MUC5AC by IAV. Methods : Using epithelial cells, C57/Bl6 mice, and IAV strains, we measured MUC5AC expression at the RNA and protein levels, Sp1 activation and protease activity. Intermediate molecular partners were confirmed using pharmacological inhibitors, blocking antibodies, and si RNAs. Measurements and main Results : We showed in vitro and in vivo, that IAV up-regulates epithelial cell-derived MUC5AC and Muc5ac expression in mice, both at transcriptional (through Sp1 induction) and translational levels. In addition, we determined that this induction was dependent upon a protease-EGFR-ERK-Sp1 signalling cascade, involving in particular the human airway trypsin (HAT). Conclusion : Our data point to MUC5AC as a potential modulatory mechanism by which the lung epithelium respond to IAV infection, and dissect, for the first time, the molecular partners involved. Future experiments using MUC5AC-targeted strategies should help to further unravel the pathophysiological consequences of IAV-induced MUC5AC expression for lung homeostasis.

PMID:
22383584
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/22383584
 
Back
Top Bottom